GV has participated in a series A round for Genomics Medicine Ireland, joining investors such as the government-owned Ireland Strategic Investment Fund.

Ireland-based life sciences company Genomics Medicine Ireland (GMI) received $40m in series A funding yesterday from a consortium including GV, the corporate venturing arm of internet and technology conglomerate Alphabet.

The round also featured venture capital firms Arch Venture Partners and Polaris Partners as well as the Ireland Strategic Investment Fund, an $8.1bn vehicle managed by the Irish government-owned National Treasury Management Agency.

Founded in 2015, GMI is working on a platform that aims to collect genomic data and identify…